In addition, significantly increased BAL fluid levels of the protease inhibitors SLPI and elafin were found during the mid/late phase compared with the acute phase of the coinfection in patients with COVID-19 (but not with influenza) (Figure 7, K and L). The gene discussed is SLPI; the disease is COVID-19.